N,4-Dimethyl-N-((triisopropylsilyl)ethynyl)benzenesulfonamide

Catalog No. :
ACVXDS074
CAS No. :
1007597-63-8
Molecular Formula :
C19H31NO2SSi
Molecular Weight :
365.61

IUPAC Name:N,4-dimethyl-N-((triisopropylsilyl)ethynyl)benzenesulfonamide

N,4-Dimethyl-N-((triisopropylsilyl)ethynyl)benzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$285.00Login to see priceIn stockInquiry
1g95%$766.00Login to see priceIn stockInquiry
5g95%$2681.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN,4-Dimethyl-N-((triisopropylsilyl)ethynyl)benzenesulfonamide
IUPAC NameN,4-dimethyl-N-((triisopropylsilyl)ethynyl)benzenesulfonamide
MDL No.MFCD31657901
Molecular FormulaC19H31NO2SSi
Molecular Weight365.61
SMILESCC(C)[Si](C(C)C)(C#CN(S(C1=CC=C(C)C=C1)(=O)=O)C)C(C)C
InChI KeyCXOGCFZBPJZIKO-UHFFFAOYSA-N
SynonymN,4-Dimethyl-N-[(triisopropylsilyl)ethynyl]benzenesulfonamide;Benzenesulfonamide, N,4-dimethyl-N-[2-[tris(1-methylethyl)silyl]ethynyl]-
CAS No.1007597-63-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACVXDS074 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVXDS074 route product structure diagram
    ACVXDS0741007597-63-8 In Stock
Inquiry

2. ACVXDS074 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVXDS074 route product structure diagram
    ACVXDS0741007597-63-8 In Stock
Inquiry

Comments (0)